Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Vanda Pharmaceuticals Inc (NASDAQ: VNDA) improved of late. VNDA’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
On 3/8/24, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock increased 1.3%, closing at $3.87. This advance was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months and has declined -13.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.
Vanda Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Vanda Pharmaceuticals has a good Appreciation Score of 78 but a very low Power Rating of 14, triggering the Low Neutral Value Trend Rating.
Be the first to comment